Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (Infuse) in posterolateral lumbar spine fusion: A case report

Spine

Volumn 37, Issue 8, 2012, Pages

  Anderson, Christopher L ^a   Whitaker, M Camden ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

bone morphogenetic protein (BMP); heterotopic ossifi cation; posterolateral spinal fusion; rhBMP 2 (Infuse)

Indexed keywords

INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

AGED; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HETEROTOPIC OSSIFICATION; HUMAN; LUMBAR SPINE; MYELOGRAPHY; PRIORITY JOURNAL; REVIEW; SPINE FUSION; SPINE SURGERY;

AGED; BONE MORPHOGENETIC PROTEIN 2; FEMALE; HUMANS; LOW BACK PAIN; LUMBAR VERTEBRAE; OFF-LABEL USE; OSSIFICATION, HETEROTOPIC; SPINAL FUSION;

EID: 84859944297     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318238870b     Document Type: Review

References (17)

1. Arringtion ED, Smith WJ, Chambers HG, et al. Complications of iliac crest bone graft harvesting. Clin Orthop 1996; 329: 300-9. (Pubitemid 26274684)
2. Boden SD. Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 2002; 27: S26-31.
3. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-9.
4. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Defi nitive evidence of osteoinduction in humans: a preliminary report. Spine 2002; 25: 376-81. (Pubitemid 30097051)
5. Burkus JK, Heim SE, Gornet MF, et al. Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device. J Spinal Disord Tech 2003; 16: 113-22.
6. Joseph V, Rampersaud YR. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion. Spine 2007; 32: 2885-90. (Pubitemid 351339361)
7. Lewandrowski K, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of fi ve cases. Spine J 2007; 7: 609-14. (Pubitemid 47471438)
8. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006; 19: 483-6. (Pubitemid 44526745)
9. Shields LB, Raque GH, Glassman SD, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein- 2 use in anterior cervical spine fusion. Spine 2006; 31: 542-47.
10. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990; 87: 2220-4.
11. Fujimura K, Bessho K, Kusumoto K, et al. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995; 208: 316-22.
12. Bessho K, Carnes DL, Cavin R, et al. Experimental studies on bone induction using low-molecular-weight poly as a carrier for recombinant human bone morphogenetic protein-2. J Biomed Mater Res 2002; 61: 61-5. (Pubitemid 34650257)
13. Mimatsu K, Kishi S, Hashizume Y. Experimental chronic compression on the spinal cord of the rabbit by ectopic bone formation in the ligamentum fl avum with bone morphogenetic protein. Spinal Cord 1997; 35: 740-6. (Pubitemid 27490315)
14. Martin GJ, Boden SD, Morone MA, et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman safety. J Spinal Disord 1999; 12: 179-89.
15. Poynton AR, Lane JM. Safety profi le for the clinical use of bone morphogenetic proteins in the spine. Spine 2002; 27: S40-8.
16. Haid RW, Branch CL, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004; 4: 527-39.
17. Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of offlabel PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2007; 8: 203-5.